Are you a Knight ADRC affiliated researcher with a news article you would like us to post?
Contact Us
$9 million to fund study of ‘jumping genes’ in Alzheimer’s (Links to an external site)
A five-year, $9 million grant from the National Institute on Aging of the National Institutes of Health (NIH) will fund research led by several investigators at Washington University School of Medicine in St. Louis and at the University of Texas at San Antonio to answer that question.
Better Cognitive Predictor in People at High Risk of Alzheimer’s Disease (Links to an external site)
The Alzheimer’s disease (AD) drug lecanemab’s recent success in Biogen’s Phase III clinical trials might have more to do with its effect in increasing levels of soluble amyloid-beta than in decreasing amyloid plaques in the brain, the findings of a new study published in the Journal of Alzheimer’s Disease on October 4, 2022, suggests.
Cruchaga awarded Zenith Fellowship Award (Links to an external site)
Carlos Cruchaga, PhD, the Barbara Burton and Reuben M. Morriss III Professor in psychiatry, is one of three Zenith Fellows selected this year and one of only 146 Alzheimer’s researchers chosen for the honor since it was created in 1991.
Washington University researcher finds Hispanic community more likely to develop Alzheimer’s (Links to an external site)
Dr. Jorge Llibre is a Washington University neurologist that researches Alzheimer’s. He says research shows the Hispanic community is two times more likely to develop Alzheimer’s or dementia than non-Hispanics.
Risk of Alzheimer’s dementia may be predicted with help of new tool (Links to an external site)
Using demographic information, brain imaging test results and genetic biomarkers, researchers at Washington University School of Medicine in St. Louis have developed an algorithm that can help provide people who volunteer for studies of aging with information about the risk each faces of developing dementia due to Alzheimer’s disease.